124 related articles for article (PubMed ID: 7676293)
1. [Multiple myeloma: ambulatory chemotherapy--nursing care techniques].
Houis P; Jubert-Leleu MC
Soins; 1994 Oct; (589):28, 30-3. PubMed ID: 7676293
[No Abstract] [Full Text] [Related]
2. [Economic impact of outpatient chemotherapy in multiple myeloma].
Coutet J; Limat S; Voillat L; Deconinck E; Cahn JY; Woronoff-Lemsi MC
Bull Cancer; 2004 Sep; 91(9):729-34. PubMed ID: 15544999
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy of multiple myeloma].
Estape J; Antón I; Daniels M; Bladé J; Domingo A; Rubio D
Sangre (Barc); 1984; 29(5):936-9. PubMed ID: 6523344
[No Abstract] [Full Text] [Related]
4. [Indications for chemotherapy in multiple myeloma].
Heyll A; Aul C
Dtsch Med Wochenschr; 1996 May; 121(20):675. PubMed ID: 8635404
[No Abstract] [Full Text] [Related]
5. Multiple myeloma: current management.
Alexanian R; Barlogie B
Tex Med; 1985 Oct; 81(10):24-6. PubMed ID: 4060076
[No Abstract] [Full Text] [Related]
6. Multiple myeloma in the era of novel agents.
Dimopoulos MA; Attal M
Semin Hematol; 2009 Apr; 46(2):107-9. PubMed ID: 19389493
[No Abstract] [Full Text] [Related]
7. [Are drug combinations useful in multiple myeloma?].
Pavlovsky S
Sangre (Barc); 1984; 29(5):872-5. PubMed ID: 6523339
[No Abstract] [Full Text] [Related]
8. Strategies in treating newly diagnosed or untreated multiple myeloma patients. From the Multiple Myeloma Research Foundation.
Weber DM
Oncology (Williston Park); 2003 Jun; 17(6):765-7. PubMed ID: 12846120
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of multiple myeloma. Chemotherapy in primary and secondary therapeutic failure in renal failure].
Pflüger KH; Görg K; Görg C; Havemann K
Med Klin (Munich); 1987 Jan; 82(1):16-22. PubMed ID: 3561340
[No Abstract] [Full Text] [Related]
10. [Results, failures and perspectives in therapy of multiple myeloma].
Bessmel'tsev SS; Abdulkadyrov KM
Vopr Onkol; 2002; 48(2):146-52. PubMed ID: 12227061
[No Abstract] [Full Text] [Related]
11. Combo drug therapy beneficial for new cases of multiple myeloma.
Health News; 2006 Feb; 12(2):9. PubMed ID: 16456922
[No Abstract] [Full Text] [Related]
12. Thalidomide with continuous low-dose dexamethasone for multiple myeloma.
Gardyn J
J Clin Oncol; 2005 Feb; 23(6):1323. PubMed ID: 15718336
[No Abstract] [Full Text] [Related]
13. Treatment of multiple myeloma. A small step forward?
Kyle RA
N Engl J Med; 1984 May; 310(21):1382-4. PubMed ID: 6371531
[No Abstract] [Full Text] [Related]
14. [Outpatient chemotherapy].
Fasano M
Soins Gynecol Obstet Pueric Pediatr; 1992; (135-136):28-32. PubMed ID: 1336214
[No Abstract] [Full Text] [Related]
15. [Therapy of multiple myeloma and monitoring of the response].
Rapazzini P; Bettini R; Masini M; Steidl L; Ferrari V; Piantanida S
Recenti Prog Med; 1986 Feb; 77(2):95-9. PubMed ID: 3715177
[No Abstract] [Full Text] [Related]
16. [Chemotherapy of plasmacytoma].
Kraj M
Pol Tyg Lek; 1983 Apr; 38(16):477-80. PubMed ID: 6356085
[No Abstract] [Full Text] [Related]
17. Advances in the treatment of elderly patients with multiple myeloma.
Facon T
Clin Adv Hematol Oncol; 2006 Jul; 4(7):501-2. PubMed ID: 17147234
[No Abstract] [Full Text] [Related]
18. Thalidomide and dexamethasone: a new standard of care for initial therapy in multiple myeloma.
Richardson P; Anderson K
J Clin Oncol; 2006 Jan; 24(3):334-6. PubMed ID: 16365174
[No Abstract] [Full Text] [Related]
19. The refractory patient: new treatment options.
Schuster MW
Oncology (Williston Park); 2003 Oct; 17(10):1333-5. PubMed ID: 14606360
[No Abstract] [Full Text] [Related]
20. High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma.
Gertz MA; Lacy MQ; Dispenzieri A; Hayman SR; Kumar SK
Expert Rev Anticancer Ther; 2006 Mar; 6(3):343-60. PubMed ID: 16503852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
